Resveratrol, a polyphenolic phytoalexin attenuates thermal hyperalgesia and cold allodynia in STZ-induced diabetic rats

Indian Journal of Experimental Biology

Volumn 44, Issue 7, 2006, Pages 566-569

  Sharma, Sameer ^a   Kulkarni, S K ^a   Chopra, Kanwaljit ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Diabetic neuropathy; Hyperalgesia; Oxidative stress; Resveratrol

Indexed keywords

ANTIOXIDANT; PHYTOALEXINS; PLANT EXTRACT; RESVERATROL; STILBENE DERIVATIVE; TERPENE;

ANIMAL; ARTICLE; BLOOD; BODY WEIGHT; COLD; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HEAT; HYPERALGESIA; IMMERSION; MALE; PATHOPHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; BODY WEIGHT; COLD; DIABETES MELLITUS, EXPERIMENTAL; HEAT; HYPERALGESIA; IMMERSION; MALE; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; STILBENES; TERPENES;

ANIMALIA;

EID: 33745902804     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Haworth R S & Avkiran M, Inhibition of protein kinase D by resveratrol, Biochem Pharmacol, 62 (2001)1647.
2. Holian O, Wahid S, Atten M J & Attar BM, Inhibition of gastric cancer cell proliferation by resveratrol; role of nitric oxide, Am J Physiol Gastrointest Liver Physiol, 282 (2002) G809.
3. Kowluru R A, Abbas S N & Odenbach S, Reversal of hyperglycemia and diabetic nephropathy: effect of reinstitution of good metabolic control on oxidative stress in the kidney of diabetic rats, J Diabetes Complications, 18 (2004) 282.
4. Delmas D, Jannin B & Latruffe N, Resveratrol: preventing properties against vascular alterations and ageing, Mol Nutr Food Res, 49 (2005) 377.
5. Blumenstein I, Keseru B, Wolter F & Stein J, The chemopreventive agent resveratrol stimulates cyclic AMP-dependent chloride secretion in vitro, Clin Cancer Res, 11 (2005) 5651.
6. Stewart J R & O'Brian C A, Resveratrol Antagonizes EGFR-dependent Erk1/2 Activation in Human androgen-independent prostate cancer cells with associated isozyme-selective PKC alpha inhibition. Invest New Drugs 22 (2004) 107.
7. Atten M J, Attar B M, Milson T & Holian O, Resveratrol-induced inactivation of human gastric adenocarcinoma cells through a protein kinase C-mediate mechanism, Biochem Pharmacol, 62 (2001) 1423.
8. Bowers J L, Tyulmenkov V V, Jernigan S C & Klinge C M, Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta, Endocrinology, 141 (2000) 3657.
9. Murali B & Goyal R K, Effect of chronic treatment with losartan on streptozotocin induced diabetic nephropathy, Clin Exp Hypertens, 23 (2001) 513.
10. Schmidt F H, Methoden der har-und blutzuckerbestrimmung II. Handbuch Des, Diabetes Mellitus, 2 (1971) 938.
11. Anjaneyulu M & Ramarao P, Studies on gastrointestinal tract functional changes in diabetic animals, Methods Find Exp Clin Pharmacol, 2 (2002) 71.
12. Jain N K, Patil C S, Singh A & Kulkarni S K, Sildenafil-induced peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway, Brain Res, 909 (2001) 170.
13. Attal N, Jazat F, Kayser V & Guilbaud G, Further evidence for pain-related behaviours in a model of unilateral peripheral mononeuropathy, Pain, 41 (1990) 235.
14. Calcutt N A, Jorge M C, Yaksh T L & Cahplan S R, Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine, Pain, 68 (1996) 293.
15. Ahlgreen S C & Levine J D, Mechanical hyperalgesia in streptozotocin-diabetic rats, Neuroscience, 52 (1993) 1049.
16. Coopey L J, Gellett J S, Davidson E P, Dunlap J A, Lund D D & Yorec M A, Effect of antioxidant treatment of streptozotocin-induced diabetic rats in endoneurial blood flow, motor nerve conduction velocity and vascular reactivity of epineurial arterioles of the sciatic nerve, Diabetes, 50 (2001) 1927.
17. Anjaneyulu M & Chopra K, Effect of Irbesartan on the Antioxidant Defence System and Nitric Oxide Release in Diabetic Rat Kidney, Am J Nephrol, 24 (2004) 488.
18. Patil C S, Singh V P, Singh S & Kulkarni S K, Modulatory effect of the PDE-5 inhibitor Sildenafil in Diabetic Neuropathy, Pharmacology, 72 (2004) 190.
19. Tsai S H, Lin-Shiau S Y & Lin J K, Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol, Br J Pharmacol, 126 (1999) 673.
20. Schmeichel A M, Schmelzer J D & Phillip A, Low Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy, Diabetes,52 (2003) 165.
21. Lin J K & Tsai S H, Chemoprevention of cancer and cardiovascular disease by resveratrol, Proc Natl Sci Counc Repub China B, 23 (1999) 99.
22. 2 and nitric oxide in inducible nitric oxide synthase expression in macrophages, Nitric Oxide, 5 (2001) 504.
23. Slater S J, Seiz J L, Cook A C, Stagliano B A & Buzas C J, Inhibition of protein kinase C by resveratrol, Biochem Biophys Acta,1631 (2003) 59.
24. Rochelle L G, Fischer B M & Adler K B, Concurrent production of reactive oxygen and nitrogen species by airway epithelial cells in vitro, Free Radic Biol Med, 24 (1998) 863.